Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Couvineau

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|June 17, 2003
Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptorYossan-Var Tan, Alain Couvineau, Jean Van Rampelbergh, et al.
Peptides|August 9, 2007
Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/inflammatory challengeGeraldine Favrais, Alain Couvineau, Marc Laburthe, et al.
World Journal of Gastroenterology|December 15, 2021
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctionsAlain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Annals of the New York Academy of Sciences|August 5, 2006
Characterization of the new photoaffinity probe (Bz2-K24)-VIPYossan-Var Tan, Alain Couvineau, Jean Jacques Lacapere, et al.
British Journal of Pharmacology|August 19, 2015
Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesisPascal Nicole, Pierre Couvineau, Nadege Jamin, et al.
Scientific Reports|August 22, 2025
Non-canonical G<sub>q</sub> activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulationsPaulina Dragan, Valerie Gratio, Thierry Voisin, et al.
The Journal of Biological Chemistry|July 23, 2002
Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin bindingKai Du, Alain Couvineau, Christiane Rouyer-Fessard, et al.
Journal of Molecular Neuroscience : MN|July 4, 2008
The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptorEmilie Ceraudo, Yossan-Var Tan, Pascal Nicole, et al.
International Journal of Molecular Sciences|June 10, 2023
Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha InfliximabAnne Blais, Annaïg Lan, François Blachier, et al.
Journal of Biotechnology|March 20, 2012
Intestinal cell targeting of a stable recombinant Cu-Zn SOD from Cucumis melo fused to a gliadin peptideLaurent Intes, Muriel Bahut, Pascal Nicole, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|June 17, 2003
Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptorYossan-Var Tan, Alain Couvineau, Jean Van Rampelbergh, et al.
Peptides|August 9, 2007
Involvement of VIP and PACAP in neonatal brain lesions generated by a combined excitotoxic/inflammatory challengeGeraldine Favrais, Alain Couvineau, Marc Laburthe, et al.
World Journal of Gastroenterology|December 15, 2021
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctionsAlain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Annals of the New York Academy of Sciences|August 5, 2006
Characterization of the new photoaffinity probe (Bz2-K24)-VIPYossan-Var Tan, Alain Couvineau, Jean Jacques Lacapere, et al.
British Journal of Pharmacology|August 19, 2015
Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesisPascal Nicole, Pierre Couvineau, Nadege Jamin, et al.
Scientific Reports|August 22, 2025
Non-canonical G<sub>q</sub> activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulationsPaulina Dragan, Valerie Gratio, Thierry Voisin, et al.
The Journal of Biological Chemistry|July 23, 2002
Human VPAC1 receptor selectivity filter. Identification of a critical domain for restricting secretin bindingKai Du, Alain Couvineau, Christiane Rouyer-Fessard, et al.
Journal of Molecular Neuroscience : MN|July 4, 2008
The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptorEmilie Ceraudo, Yossan-Var Tan, Pascal Nicole, et al.
International Journal of Molecular Sciences|June 10, 2023
Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha InfliximabAnne Blais, Annaïg Lan, François Blachier, et al.
Journal of Biotechnology|March 20, 2012
Intestinal cell targeting of a stable recombinant Cu-Zn SOD from Cucumis melo fused to a gliadin peptideLaurent Intes, Muriel Bahut, Pascal Nicole, et al.
Pageof 6